|
|
Severe Weight Loss in HIV / HCV-coinfected Patients Treated With Interferon Plus Ribavirin: Incidenc
|
| Link ID |
8147 |
| Title |
Severe Weight Loss in HIV / HCV-coinfected Patients Treated With Interferon Plus Ribavirin: Incidenc |
| Url |
http://www.medscape.com/viewarticle/579246?src=rss |
| Description |
Weight loss is reported by more than 20% of HCV-monoinfected patients treated with the peg-interferon (peg-IFN) and ribavirin combination. The aim of this study was to determine the incidence and risk factors of severe weight loss HIV / HCV-coinfected patients.
Journal of Viral Hepatitis |
| Category |
Articles > HIV/AIDS |
| Keywords |
|
| Date |
Aug 27, 2008 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > HIV/AIDS |
| 1. |
Episodic ART Increases Long-Term Risk of Opportunistic Infections and Death
|
|
|
The risk of HIV-related infections and death remains elevated for at least 18 months after patients resume antiretroviral therapy (ART) following a planned treatment interruption, results of the multinational SMART (Strategies for Management of Anti-Retroviral Therapy) study indicate. Reuters Health Information
|
|
|